Alladapt Immunotherapeutics, Inc.

Navigator Medicines unveiled its plans to develop novel medicines for complex, heterogeneous autoimmune diseases on 27 August, revealing that it has raised $100m in series A funding from RA Capital M

Red Tree Venture Capital hopes to provide early-stage VC funding to life science start-ups emerging from academic and research institutions on the West Coast – funding that, the firm believes, has bee

Two more small biopharmaceutical companies managed to launch initial public offerings recently, bringing the 2022 total to 17 drug developers that have gone public in the US this year, despite the fac

The number of biopharmaceutical companies raising venture capital this year has far outpaced the number raising money in public offerings, with 126 venture rounds during the first quarter versus just